Difference between revisions of "Team:San Andres/Software"

 
(27 intermediate revisions by the same user not shown)
Line 2: Line 2:
  
 
<head data-gwd-animation-mode="quickMode">
 
<head data-gwd-animation-mode="quickMode">
 +
  <title>&lt;endnote&gt;&lt;head&gt; &lt;title&gt;&lt;endnote&gt;&lt;head&gt; &lt;meta&gt; &lt;title&gt;
 +
  </title>
 +
</head>
 +
 +
<body>
 +
  <title>wiki</title>
 +
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
 +
  <meta name="generator" content="Google Web Designer 1.3.2.0521">
 +
  <style type="text/css">
 +
    html, body {
 +
      width: 100%;
 +
      height: 100%;
 +
      margin: 0px;
 +
    }
 +
    body {
 +
      -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
 +
      -webkit-transform-style: preserve-3d;
 +
      background-image: url(https://static.igem.org/mediawiki/2015/8/8a/BBD7.jpg);
 +
      background-color: rgb(198, 169, 117);
 +
    }
 +
  </style>
 +
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 +
  <title></title>
 +
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 +
  <title></title>
 +
  <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 +
  <title></title>
 
   <title>wiki</title>
 
   <title>wiki</title>
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
 
   <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
Line 17: Line 44:
 
     }
 
     }
 
   </style>
 
   </style>
</head>
 
 
<body class="gwd-body-kwce">
 
 
   <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 
   <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1">
 
   <title></title>
 
   <title></title>
Line 128: Line 152:
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
 
       background-color: transparent;
 
       background-color: transparent;
 +
    }
 +
    .gwd-table-nb4m {
 +
      font-size: 24px;
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 +
      background-image: none;
 +
      background-color: rgb(255, 255, 255);
 
     }
 
     }
 
     .gwd-td-b6db {
 
     .gwd-td-b6db {
Line 508: Line 539:
 
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1);
 
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1);
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
    }
 
    .gwd-img-l2p5 {
 
      position: absolute;
 
      width: 135px;
 
      left: -160px;
 
      top: 26px;
 
 
     }
 
     }
 
     .gwd-img-n53q {
 
     .gwd-img-n53q {
Line 534: Line 559:
 
     }
 
     }
 
     .gwd-a-36ww {
 
     .gwd-a-36ww {
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
+
       -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, -16.1, 0.05, 0, 1);
 
       -webkit-transform-style: preserve-3d;
 
       -webkit-transform-style: preserve-3d;
 
     }
 
     }
Line 545: Line 570:
 
       top: 349.384236453212px;
 
       top: 349.384236453212px;
 
       width: 250px;
 
       width: 250px;
 +
    }
 +
    .gwd-img-zpsn {
 +
      position: absolute;
 +
      width: 150px;
 +
      left: -165.73913043478px;
 +
      top: 49.3260869565235px;
 +
    }
 +
    .gwd-a-d01x {
 +
      -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1);
 +
      -webkit-transform-style: preserve-3d;
 +
    }
 +
    .gwd-table-10nh {
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 +
    }
 +
    .gwd-table-15ao {
 +
      -webkit-transform: translate3d(0px, -2px, 0px);
 +
      -webkit-transform-style: preserve-3d;
 
     }
 
     }
 
   </style>
 
   </style>
 
   <!--navigation menu -->
 
   <!--navigation menu -->
 
   <br>
 
   <br>
 +
  <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-15ao">
 +
    <tbody>
 +
      <tr heigth="15px">
 +
      </tr>
 +
      <tr heigth="75px">
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres" style="color: rgb(0, 0, 0);">Home </a>
 +
        </td>
 +
        <td style="border: 3px solid black;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Team" style="color: rgb(0, 0, 0);"> Team</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Description" style="color: rgb(0, 0, 0);"> Project</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Parts" style="color: rgb(0, 0, 0);"> Parts</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Modeling" style="color: rgb(0, 0, 0);"> Modeling</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><a href="https://2015.igem.org/Team:San_Andres/Results" style="color: rgb(0, 0, 0);"> Results</a>
 +
        </td>
 +
      </tr>
 +
    </tbody>
 +
  </table>
 +
  <table style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-10nh">
 +
    <tbody>
 +
      <tr heigth="15px">
 +
      </tr>
 +
      <tr heigth="75px">
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Notebook" style="color: rgb(0, 0, 0);">Notebook</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Practices" style="color: rgb(0, 0, 0);"> Human Practices</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Design" style="color: rgb(0, 0, 0);"> Future Projections</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Attributions" style="color: rgb(0, 0, 0);"> Attributions</a>
 +
        </td>
 +
        <td style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'">
 +
          <a href="https://2015.igem.org/Team:San_Andres/Collaborations" style="color: rgb(0, 0, 0);"> Collaborations</a>
 +
        </td>
 +
      </tr>
 +
    </tbody>
 +
  </table>
 
   <div class="gwd-div-2ed9"></div>
 
   <div class="gwd-div-2ed9"></div>
 
   <div class="gwd-div-7xzo gwd-a-1thu">
 
   <div class="gwd-div-7xzo gwd-a-1thu">
     <h1>Collaborations</h1>
+
     <h1>Abstract</h1>
     <big>So the project could be carried out we have the
+
     <div style="text-align: justify;"><big>The celiac
collaboration of two teams IGEM (<a href="https://2015.igem.org/Team:Colegio_EmelinaU">EmelinaU</a>
+
disease affects 1 in 265 people worldwide and 15%
and&nbsp;<a href="https://2015.igem.org/Team:Liceo_Eugenio_Hostos">Hostos</a>),
+
of population in Chile. This in an irreversible autoimmune disease in
since we work together in the same laboratory and share some parts of
+
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
our Biobricks. We also have the contribution of teams <a href="https://2011.igem.org/Team:Washington">Washintong 2011</a>
+
affected, the consumption of foods containing gluten (all fods derived
and&nbsp;<a href="https://2012.igem.org/Team:Colorado_State/Project">Colorado
+
from wheat, barley, rye, etc.) cause an inflammation in small intestine
2012</a> , since their research served as references in our. <br>
+
causing multiple effects in the organism (diarrhea, constipation, porr
<br>
+
absorption, among others) significantly affecting their quatily of life.</big>
 +
      <br>
 +
      <br>
 +
      <big>Whereas the majority of the world food contains gluten, we
 +
propose a
 +
treatment for those who can't eat gluten, and can do so without
 +
problems. In detail, our project involves a system able to degrade
 +
gluten via the enzyme KumaMax and report the operation simultaneously
 +
with a red fluorescent protein. The foregoing, works in a genetically
 +
modified E. coli bacteria. With this project, in long run, we hope to
 +
improve the quality of life of all those reported with celiac disease.
 +
People who suffer from gluten intolerance have an adverse reaction to
 +
gluten proteins found in wheat, barley, and rye products.</big>
 +
      <br>
 +
    </div>
 +
    <big><br>
 
</big>
 
</big>
 
     <div style="text-align: center;">
 
     <div style="text-align: center;">
       <img alt="https://static.igem.org/mediawiki/2015/e/e5/Grupo_800.jpg" src="https://static.igem.org/mediawiki/2015/e/e5/Grupo_800.jpg">
+
       <img style="width: 893px; height: 373px;" alt="File:Ex 2.jpg" src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg">
 +
    </div>
 +
    <p class="MsoListParagraph" style="text-indent: -18pt;">
 
       <br>
 
       <br>
      <br>
+
    </p>
      <h1 style="text-align: left;">References</h1>
+
    <p class="MsoListParagraph" style="text-indent: -18pt;"></p>
      <div style="text-align: left;"><big>1.&nbsp;</big><big>Structural
+
Basis for Gluten Intolerance in Celiac Sprue (2002)<br>
+
2. Seminar Coeliac Disease (2003)<br>
+
3.&nbsp;Mortality in celiac disease (2010)<br>
+
4.&nbsp;Crystallographic and Biochemical Investigations of
+
Kumamolisin-As, a Serine-Carboxyl Peptidase with Collagenase Activity
+
(2004)<br>
+
5.&nbsp;Epilepsy, cerebral calcifications and clinical or
+
subclinical coeliac disease. Course and follow up with gluten-free diet
+
(1998)<br>
+
6.&nbsp;Coeliac disease on the rise in Europe (2010)<br>
+
7.&nbsp;Should coeliac sufferers be allowed their oats? (2007)<br>
+
8.&nbsp;Prevalence of Celiac Disease among Children in Finland
+
(2001)<br>
+
9.&nbsp;Protein engineering of improved prolyl endopeptidases for
+
celiac sprue therapy (2008)<br>
+
10. Undiagnosed coeliac disease and risk of autoimmune disorders in
+
subjects with Type I diabetes mellitus (2001)<br>
+
11.&nbsp;Analytical Methods for Detection of Gluten in Food—Method
+
Developments in Support of Food Labeling Legislation (2011)<br>
+
<span style="font-weight: bold;"></span></big>
+
        <span style="font-family: &quot;Segoe UI&quot;,&quot;sans-serif&quot;;"></span>
+
      </div>
+
    </div>
+
    <br>
+
    <strong></strong>
+
 
   </div>
 
   </div>
  <br>
 
  <div class="gwd-div-a9c8"></div>
 
 
   <br>
 
   <br>
 
   <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww">
 
   <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww">
     <img style="border: 0px solid ; width: 150px; height: 150px; top: 35px; left: 989px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf">
+
     <img style="border: 0px solid ; width: 150px; height: 150px; left: 989px; top: 49px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf">
 
   </a>
 
   </a>
   <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx">
+
   <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx gwd-a-d01x">
     <img src="https://static.igem.org/mediawiki/2015/thumb/9/94/Logo43.png/454px-Logo43.png" class="gwd-img-l2p5">
+
     <img src="https://static.igem.org/mediawiki/2015/thumb/8/85/Logo_Definitvo.png/654px-Logo_Definitvo.png" class="gwd-img-zpsn">
 
   </a>
 
   </a>
 
   <br>
 
   <br>
 
   <br>
 
   <br>
   <div class="gwd-div-t5nw gwd-div-6h0e">
+
   <br>
    <style>
+
  <br>
      body {
+
   <br>
        font-family: Arial;
+
      }
+
      nav ul {
+
        list-style: none;
+
        padding: 0px;
+
      }
+
      nav li {
+
        line-height: 3rem;
+
        position: relative;
+
        width: 190px;
+
      }
+
      nav li ul {
+
        position: absolute;
+
      }
+
      nav a {
+
        color: rgb(0, 0, 0);
+
        display: block;
+
        padding: 0px 2.5em;
+
        text-decoration: none;
+
        transition: 0.3s;
+
        -webkit-transition: 0.3s;
+
      }
+
      nav a:hover {
+
        background: rgb(255, 186, 0);
+
      }
+
      nav li ul {
+
        display: none;
+
      }
+
      nav li:hover ul {
+
        display: block;
+
      }
+
      nav > ul {
+
        display: table;
+
        width: 100%;
+
        background: rgb(255, 166, 0);
+
      }
+
      nav > ul > li {
+
        float: left;
+
      }
+
      nav li li {
+
        max-height: 0px;
+
        transition: all 0.1s;
+
        -webkit-transition: all 0.1s;
+
        overflow: hidden;
+
        width: 200px;
+
        background: rgb(237, 173, 0);
+
      }
+
      nav li:hover > ul > li {
+
        max-height: 500px;
+
        overflow: visible;
+
      }
+
      nav > ul > li > ul {
+
        top: 100%;
+
      }
+
      .gwd-nav-nvls {
+
        -webkit-transform: translate3d(-13.57px, 349.01px, 0px);
+
        -webkit-transform-style: preserve-3d;
+
      }
+
      .gwd-div-6h0e {
+
        -webkit-transform: translate3d(-5.08px, -1535.01px, 0px);
+
        -webkit-transform-style: preserve-3d;
+
      }
+
    </style>
+
    <nav class="gwd-nav-nvls">
+
      <ul>
+
        <li><a href="https://2015.igem.org/Team:San_Andres">Home</a>
+
        </li>
+
        <li><a href="https://2015.igem.org/Team:San_Andres/Team">Team</a>
+
        </li>
+
        <li><a href="https://2015.igem.org/Team:San_Andres/Description">Project</a>
+
          <ul>
+
            <li><a href="https://2015.igem.org/Team:San_Andres/Parts">Parts</a>
+
            </li>
+
            <li><a href="https://2015.igem.org/Team:San_Andres/Modeling">Modeling</a>
+
            </li>
+
            <li><a href="https://2015.igem.org/Team:San_Andres/Results">Results</a>
+
            </li>
+
          </ul>
+
        </li>
+
        <li><a href="https://2015.igem.org/Team:San_Andres/Notebook">Notebook</a>
+
          <ul>
+
            <li><a href="https://2015.igem.org/Team:San_Andres/Practices">Human Practices</a>
+
            </li>
+
            <li><a href="https://2015.igem.org/Team:San_Andres/Design">Future Projections</a>
+
            </li>
+
          </ul>
+
        </li>
+
        <li><a href="https://2015.igem.org/Team:San_Andres/Collaborations">Collaborations</a>
+
        </li>
+
      </ul>
+
    </nav>
+
   </div>
+
 
</body>
 
</body>
  
 
</html>
 
</html>

Latest revision as of 01:22, 15 September 2015

<endnote><head> <title><endnote><head> <meta> <title> wiki wiki exp wiki wiki wiki 2   File:Gluten-s-Job.jpeg

Home Team Project Parts Modeling Results
Notebook Human Practices Future Projections Attributions Collaborations

Abstract

The celiac disease affects 1 in 265 people worldwide and 15% of population in Chile. This in an irreversible autoimmune disease in which due to the presence of genes HLA DQ2 or HLA DQ8 in those affected, the consumption of foods containing gluten (all fods derived from wheat, barley, rye, etc.) cause an inflammation in small intestine causing multiple effects in the organism (diarrhea, constipation, porr absorption, among others) significantly affecting their quatily of life.

Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.

File:Ex 2.jpg